Search

everythinglearnresearchcommunity

for

Search:↓

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Consider NF1 in newborns with rare congenital anomalies.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

The document summarized various dermatology studies and case reports.

An 8-year-old boy with neurofibromatosis type one also has rare hair and eye disorders.

Some people with schwannomatosis have a new type of mutation in the LZTR1 gene.

A 15-year-old girl has a skin condition causing blisters on her feet, likely inherited from her family.

Possible link between COVID-19 and hair loss; more research needed.

Skin symptoms can indicate endocrine disorders and have various treatments.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Blocking miR-27a increases sheep hair follicle stem cell growth and decreases cell death, which could help improve wool quality and treat hair loss.

The document concludes that accurate diagnosis and understanding the type of hair disorder are crucial for treating hair loss in children.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Treatments for hair loss include estrogen therapy and special shampoos.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

Laser treatment for lipomas improves quality of life with quick recovery and high satisfaction.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.